Status:
COMPLETED
Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient
Lead Sponsor:
Forest Laboratories
Conditions:
Congestive Heart Failure
Eligibility:
MALE
Phase:
PHASE2
Brief Summary
This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.
Eligibility Criteria
Inclusion
- No inclusion criteria as the patient to be included is this compassionate use protocol is currently receiving azimilide therapy
Exclusion
- Currently taking Class I or other Class III antiarrhythmic drug or other drugs that may prolong QT interval.
- Is unwilling or unable to give or understand informed consent.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00752596
Start Date
September 1 2005
End Date
July 1 2006
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Scottsdale, Arizona, United States, 85251